Symvivo Corporation
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluating the Safety, Tolerability and Immunogenicity of bacTRL-Spike Vaccine for Prevention of COVID-19 (NCT04334980) | Symvivo Corporation | 2020-11-02 |
Track Symvivo Corporation automatically
Every clearance here is in the API, with alerts when new ones post.